We did not see significantly increased CCL2 levels in plasma of mice with delayed-growth tumor compared with mice with rapid-growth tumor, even though mice with delayed-growth tumors had significantly elevated levels of CCL2 compared with tumor naive mice (Supplemental Figure 3D). The gene discussed is CCL2; the disease is neoplasm.